Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer

To discuss the timing, benefits, limitations and current controversies of multiparametric magnet resonance imaging (mpMRI) combined with fusion-guided biopsy and consider how additional incorporation of multivariable risk stratification might further improve prostate cancer diagnosis.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kesch, Claudia (VerfasserIn) , Schütz, Viktoria (VerfasserIn) , Dieffenbacher, Svenja (VerfasserIn) , Bonekamp, David (VerfasserIn) , Hadaschik, Boris (VerfasserIn) , Hohenfellner, Markus (VerfasserIn) , Radtke, Jan Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2018
In: Current opinion in urology
Year: 2018, Jahrgang: 28, Heft: 2, Pages: 172-177
ISSN:1473-6586
DOI:10.1097/MOU.0000000000000461
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/MOU.0000000000000461
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-urology/Fulltext/2018/03000/Multiparametric_MRI_fusion_guided_biopsy_for_the.13.aspx
Volltext
Verfasserangaben:Claudia Kesch, Viktoria Schütz, Svenja Dieffenbacher, David Bonekamp, Boris Alexander Hadaschik, Markus Hohenfellner, and Jan P. Radtke
Beschreibung
Zusammenfassung:To discuss the timing, benefits, limitations and current controversies of multiparametric magnet resonance imaging (mpMRI) combined with fusion-guided biopsy and consider how additional incorporation of multivariable risk stratification might further improve prostate cancer diagnosis.
Beschreibung:Gesehen am 16.04.2020
Beschreibung:Online Resource
ISSN:1473-6586
DOI:10.1097/MOU.0000000000000461